Analysts said Altaviva is an attractive option compared to rival products, informing their belief that Medtronic can ...
In September 2025, Medtronic announced it had received FDA approval and launched the Altaviva device, a minimally invasive ...
Medtronic's Altaviva wins FDA approval as a minimally invasive implant for urge urinary incontinence, offering long-lasting ...
Medical Device Network on MSN
FDA approves Medtronic’s urinary incontinence treatment device
Implantation of the device is minimally invasive, requiring no sedation or imaging, and is conducted near the ankle.
Patients who receive an Altaviva device return home with therapy activated. Medtronic says this marks a first among ...
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today that it has received U.S. Food and Drug Administration (FDA) approval for the Altaviva™ device. The minimally ...
Zacks Investment Research on MSN
Medtronic Receives FDA Nod for Altaviva Device: Stock to Gain?
Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...
World’s Smallest Rechargeable Bladder/Bowel Control System — InterStim Micro — Features Trusted MRI Technology for Full-Body 1.5 and 3 Tesla MRI Scans Only Medtronic Offers Patients Personalized ...
Medtronic is upping the ante in patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic's InterStim device, an implanted ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks GALWAY ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback